Average Ratings 0 Ratings
Average Ratings 0 Ratings
Description
DoubleJump Interchange is a collaborative platform hosted in the cloud that seamlessly merges data from both clinical and real-world environments to enhance cooperation between researchers and healthcare practitioners, ultimately aiming to improve the health of consumers. Consumers, along with their extended care teams, benefit from a diverse array of health information sourced from hospitals, clinics, and remote monitoring technologies, enabling them to engage in personalized, socially supported, and timely disease prevention and management. Researchers are provided with a rich pool of clinical, molecular, and real-world data, facilitating the discovery of new disease targets and identifying biomarkers that predict treatment responses effectively. By sharing clinical expertise throughout a network of healthcare providers, the platform strives to advance the principles of precision medicine. Furthermore, it accelerates the accessibility of intricate data sets, thereby driving innovation in both translational research and healthcare delivery processes. This interconnected approach not only enhances collaboration but also supports the overarching goal of elevating overall consumer health outcomes.
Description
Pharmaceutical companies require extensive genomic data to effectively implement precision medicine initiatives; however, they frequently rely on merely 10% of the available information for their decisions. Genomenon provides access to the complete dataset. Their Prodigy™ Patient Landscapes offer a streamlined and economical solution for natural history research, aiding the creation of therapies for rare diseases by deepening understanding of both retrospective and prospective health data. Utilizing an advanced AI-driven methodology, Genomenon conducts a thorough evaluation of each patient documented in the medical literature in a significantly reduced timeframe. Ensure you capture all relevant insights by exploring every genomic biomarker featured in published studies. Each scientific claim is substantiated by concrete evidence drawn from the medical literature, allowing researchers to uncover all genetic drivers and identify variants recognized as pathogenic in accordance with ACMG clinical standards, thereby enhancing the development process of targeted therapies. By leveraging this comprehensive approach, pharma companies can enhance their research effectiveness and ultimately improve patient outcomes.
API Access
Has API
No
API Access
Has API
Yes
Integrations
Google Cloud Platform
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Pricing Details
No price information available.
Free Trial
No
Free Version
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Deployment
Web-Based
Yes
On-Premises
No
iPhone App
No
iPad App
No
Android App
No
Windows
No
Mac
No
Linux
No
Chromebook
No
Customer Support
Business Hours
No
Live Rep (24/7)
No
Online Support
Yes
Customer Support
Business Hours
Yes
Live Rep (24/7)
No
Online Support
Yes
Types of Training
Training Docs
No
Webinars
No
Live Training (Online)
Yes
In Person
No
Types of Training
Training Docs
Yes
Webinars
Yes
Live Training (Online)
Yes
In Person
Yes
Vendor Details
Company Name
PwC
Founded
1998
Country
United Kingdom
Website
www.pwc.com/us/en/products/double-jump.html
Vendor Details
Company Name
Genomenon
Country
United States
Website
www.genomenon.com/pharma/